<bill session="115" type="s" number="2022" updated="2019-04-18T16:39:53Z">
  <state datetime="2017-10-26">REFERRED</state>
  <status>
    <introduced datetime="2017-10-26"/>
  </status>
  <introduced datetime="2017-10-26"/>
  <titles>
    <title type="official" as="introduced">A bill to amend the Federal Food, Drug, and Cosmetic Act to provide for reciprocal marketing approval of certain drugs, biological products, and devices that are authorized to be lawfully marketed abroad, and for other purposes.</title>
    <title type="short" as="introduced">Reciprocity Ensures Streamlined Use of Lifesaving Treatments Act of 2017</title>
    <title type="short" as="introduced">Reciprocity Ensures Streamlined Use of Lifesaving Treatments Act of 2017</title>
    <title type="display">Reciprocity Ensures Streamlined Use of Lifesaving Treatments Act of 2017</title>
  </titles>
  <sponsor bioguide_id="C001098"/>
  <cosponsors>
    <cosponsor bioguide_id="J000293" joined="2017-10-26"/>
    <cosponsor bioguide_id="L000577" joined="2017-11-09"/>
  </cosponsors>
  <actions>
    <action datetime="2017-10-26">
      <text>Introduced in Senate</text>
    </action>
    <action datetime="2017-10-26" state="REFERRED">
      <text>Read twice and referred to the Committee on Health, Education, Labor, and Pensions.</text>
    </action>
  </actions>
  <committees>
    <committee subcommittee="" code="SSHR" name="Senate Health, Education, Labor, and Pensions" activity="Referral"/>
  </committees>
  <relatedbills/>
  <subjects>
    <term name="Health"/>
    <term name="Congressional oversight"/>
    <term name="Drug safety, medical device, and laboratory regulation"/>
  </subjects>
  <amendments/>
  <committee-reports/>
</bill>
